Clinical trial
Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000…
NCT00480194 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00480194 |
|---|---|
| Title | Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM) |
| Official title | A Non-interventional, Non-controlled, Post-marketing Study to Obtain Knowledge of the Safety of ZyComb® (Xylometazoline Hydrochloride 0.5 mg/mL and Ipratropium Bromide 0.6 mg/mL) for Symptoms of Common Cold in a Real-life OTC Setting |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Common Cold |
| Intervention type | Drug |
| Interventions | xylometazoline hydrochloride and ipratropium bromide (ZyComb) |
| Enrollment | 1,000 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | May 30, 2007 |
| Last update posted | May 7, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: